Methods
death, intolerable angina, angina
ACUTE CORONARY SYNDROME, STABLE ANGINA
We conducted a randomized, double-blind, placebo-controlled trial of PCI in patients with stable angina. Patients stopped all antianginal medications and underwent a 2-week pre-randomization symptom assessment. Patients were randomized 1:1 to PCI or placebo and were followed for 12-weeks. The primary end point was the angina symptom score calculated daily based on the number of angina episodes, antianginal medication restarts, unblinding for intolerable angina, acute coronary syndrome, and death.